Sophiris Bio
$0.26259876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.2625
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0073 (-2.71%) Today
$0.00 (0.00%) As of 4:30 PM EDT after-hours
Why Robinhood?
You can watch Sophiris Bio and buy or sell other stocks, options, ETFs, and crypto commission-free!
About SPHS
Sophiris Bio, Inc. Common Stock, also called Sophiris Bio, is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. Read More The firm develops PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.
Employees
—
Headquarters
La Jolla, California
Founded
2003
Market Cap
8.81M
Price-Earnings Ratio
72.92
Dividend Yield
—
Average Volume
249.01K
High Today
$0.2698
Low Today
$0.226
Open Price
$0.2698
Volume
32.46K
52 Week High
$1.17
52 Week Low
$0.10